However, we were unable to observe an immediate combinatorial effect of anti-PD-1 and IRE on tumor outgrowth (Fig. 9a), and anti-PD-1 with or without IRE treatment did not affect SPAS-1+ T cell levels in the blood (Fig. 9b). This evidence concerns the gene PDCD1 and neoplasm.